|
Alnylam Pharmaceuticals, Inc. - Company Profile Snapshot
| Company Profile: |
Alnylam Pharmaceuticals, Inc. |
| Ticker: |
ALNY |
| Exchanges: |
NAS |
| 2008 Sales: |
96,163,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
170 |
Business Description
Alnylam Pharmaceuticals, Inc.. The Group's principal activity is to discovering, developing and commercializing RNA interference or RNAi therapeutics. The RNAi is a natural cellular process for selectively turning off the activity of genes. The Group is in a development stage. It operates in the United States and Germany.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
